Page 2 - Sciad Communications News Today

Taipei, Taiwan, 10th May 2023 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that the Board of Directors has approved a seasoned equity offering tha...

Cambridge and Saffron Walden, UK, 21st April 2023 / Sciad Newswire / Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises the company’s outstanding growth in international trade over three years (2019-2021) which amounted to a mor...

Connect in Pharma is promoting a new era of cross-sector collaboration within the pharmaceutical industryLondon, UK, 18 April 2023 / Sciad Newswire / The newly announced agenda for Connect in Pharma sends a strong message for more cross-sector collaboration. Technology gurus, consultancy experts and motivational spe...

Through a series of exclusive interviews and a survey of industry insiders, Connect in Pharma names the top pharmaceutical and manufacturing-related trends of 2023.  London, UK, 23 March 2023 / Sciad Newswire / A new report from Connect in Pharma published today highlights a r...

THUWAL, SAUDI ARABIA, March 8th 2023 / Sciad Newswire / King Abdullah University of Science and Technology (KAUST) is launching “Dear AI,” an International Women’s Day campaign and hackathon to tackle gender bias and the under-representation of women, Saudi and Arab people in AI software.  A recent KAUST search of a...

Taipei, Taiwan, February 20th, 2023 / Sciad Newswire / BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, is pleased to announce that Andrew Lin was elected as the new Chairman of the Boar...

London, UK, 8 February 2023 / Sciad Newswire / Empowered patients, robots and artificial intelligence are reshaping the pharmaceutical supply chain, says Dr Bertalan Meskó, Director of The Medical Futurist Institute. He will share insights on the trends influencing the future of the pharma...

Thuwal, Saudi Arabia, 2nd February 2023 / Sciad Newswire / Saudi Arabian mining company, Ma’aden, and King Abdullah University of Science and Technology (KAUST) Innovation Ventures fund invest $6 million USD collectively into Lithium Infinity (Lihytech), a startup who have developed an economically feasible way to e...

Taipei, Taiwan, 8th December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis (NK), a rare degenerative eye disease which causes ve...

Taipei, Taiwan, 1st December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E fundin...